1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. United States >
  5. California >
  6. Immucor Acquires Sirona Genomics

M&A Deal Summary

Immucor Acquires Sirona Genomics

On March 4, 2016, Immucor acquired life science company Sirona Genomics

Acquisition Highlights
  • This is Immucor’s 2nd transaction in the Life Science sector.
  • This is Immucor’s 5th transaction in the United States.
  • This is Immucor’s 2nd transaction in California.

M&A Deal Summary
Date 2016-03-04
Target Sirona Genomics
Sector Life Science
Buyer(s) Immucor
Deal Type Add-on Acquisition

Target

Sirona Genomics

Palo Alto, California, United States
Sirona Genomics, Inc. is a developer of MIA FORA NGS offering for high resolution HLA typing. MIA FORA NGS consists of an easy-to-use sample preparation protocol with a proprietary bioinformatics solution.

Search 214,356 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Immucor

Norcross, Georgia, United States
Category Company
Sector Medical Products
DESCRIPTION

Immucor, Inc. manufactures and sells a complete line of reagents and systems used by hospitals, reference laboratories, and donor centers to detect and identify certain properties of the cell and serum components of blood prior to transfusion. Immucor is based in Norcross, Georgia.

DEAL STATS #
Overall 5 of 5
Sector: Life Science M&A 2 of 2
Type: Add-on Acquisition M&A Deals 4 of 4
State: California M&A 2 of 2
Country: United States M&A 5 of 5
Year: 2016 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2014-10-01 Sentilus

Durham, North Carolina, United States

Sentilus, Inc. is a provider of a novel, inkjet-printed antibody microarray-based technology, Femtoarrays™.

Buy -
Mergr

Solution for

Product

Company

Legal